Search Stocks

Latest Key Developments (Source: Significant Developments)

Unilife Corp signs 15-year commercial supply agreement for wearable injectors with Sanofi
Monday, 6 Oct 2014 08:00am EDT 

Unilife Corp:Announces the signing of a worldwide Master Services and Commercial Supply Agreement with Sanofi to be the sole provider of cartridge based wearable injectors for all of Sanofi's applicable large dose volume drugs, excluding insulins, for a minimum 15 years.Additionally the agreement will allow Sanofi to make Unilife's wearable injectors available to its partners for use with applicable molecules under joint collaborations.Says it has granted Sanofi non-exclusive access to its wearable injector technology during the agreement.The company maintains the right to enter into supply agreements with other pharmaceutical companies for the use of its wearable injectors, so long as Sanofi's non-exclusive access is preserved.Sanofi also has the option to extend the agreement for additional periods.  Full Article

Unilife Corp reaffirms FY 2015 revenue guidance - Conference Call
Tuesday, 9 Sep 2014 04:30pm EDT 

Unilife Corp:Expect FY 2015 overall revenue to be significantly higher than FY 2014.FY 2015 revenue of $46.41 million - Thomson Reuters I/B/E/S.  Full Article

Unilife Corp gives FY 2014 and FY 2015 revenue guidance - Conference call
Monday, 12 May 2014 04:30pm EDT 

Unilife Corp:Expects that revenue for FY 2014 will end up in range of $12 mln to $15 mln.Expects that revenue for FY 2015 will be significantly higher than FY 2014.  Full Article

Unilife Corp appoints Dennis Pyers as Interim CFO
Tuesday, 18 Mar 2014 08:00am EDT 

Unilife Corp:Names Dennis Pyers as Interim CFO.Pyers replaces Richard Wieland.  Full Article

Unilife Corp secures $60 million debt financing with OrbiMed Advisors
Thursday, 13 Mar 2014 08:00am EDT 

Unilife Corp:Enters into a $60 million debt financing agreement with an affiliate of OrbiMed.$40 million was funded to Unilife at the closing of the deal.Two additional tranches of $10 million each will be provided to Unilife in December 2014 and June 2015.  Full Article

Unilife Corp's board announces issue of shares pursuant to option exercise
Monday, 24 Feb 2014 07:57pm EST 

Unilife Corp:Issues 85,000 common shares pursuant to exercise of unlisted options at an exercisable price of A$3 per option.Proceeds will be A$2,55,000.  Full Article

Unilife Corp announces dismissal of shareholder class action lawsuit
Thursday, 23 Jan 2014 12:25pm EST 

Unilife Corp:Says that a recent shareholder class action lawsuit against the company and certain corporate officers in the United States District Court for the Middle District of Pennsylvania alleging violations of federal securities laws was voluntarily dismissed by the plaintiff.  Full Article

Unilife Corp signs agreement with global pharmaceutical company seeking to use Ocu-Ject to deliver drug into eye
Monday, 16 Dec 2013 04:52pm EST 

Unilife Corp:Signs agreement with a global pharmaceutical company seeking to use the Unilife Ocu-ject ocular drug delivery system to deliver a target injectable therapy into the eye.Sys the identity of the global pharmaceutical company, one of the market leaders in ophthalmic therapies, as well as other terms of the agreement are not disclosed for commercial purposes and due to confidentiality requirements.Says it will begin to generate revenue under the program in Jan. 2014.  Full Article

Unilife Corp announces clinical supply agreement
Monday, 2 Dec 2013 05:30pm EST 

Unilife Corp:Says an agreement with Novartis to supply clinical products from one of its platforms of injectable drug delivery systems for use with one of Novartis' targeted early-stage pipeline drugs.Says Unilife will supply Novartis with a customized delivery device, consisting of syringe, needle, tubing, controller and pump.  Full Article

Unilife Corp Announces Management Change
Sunday, 24 Nov 2013 06:07pm EST 

Unilife Corp:Says appointment of Alan Shortall to Chairman of the Board of Directors, following Slavko James Joseph (Jim) Bosnjak’s decision to step down from the position for both personal and professional reasons.Says Bosnjak will remain on the Board as Deputy Chairman and Lead Independent Director.Says Ramin Mojdeh was appointed President of the Company, and will retain his position as Chief Operating Officer.  Full Article

Search Stocks